Summary: Previous studies have demonstrated that cortical spreading depression (CSD) induces neuronal tolerance to a subsequent episode of ischemia, The objective of the present investigation was to determine whether CSD alters levels of mRNA coding for putative neuroprotective proteins. Unilateral CSD was evoked in male Wistar rats by applying 2 moUL KCI over the frontal cortex for 2 hours. After recovery for 0, 2, or 24 hours, levels of several mRNA coding for neuroprotective proteins were measured bilaterally in parietal cortex using Northern blot analysis. Levels of c-fos mRNA and brain derived neurotrophic factor (BDNF) mRNA were markedly elevated at 0 and 2 hours, but not 24 hours after CSD. Tissue plasminogen activator (tPA) mRNA levels were also signifi cantly increased at 0 and 2 hours, but not 24 hours after CSD.
Preconditioning the brain with cortical spreading de pression (CSD) has been shown to reduce neuronal in jury resulting from a subsequent episode of ischemia (Kawahara et a!., 1995; Kobayashi et a!., 1995; Mat sushima et a!., 1996) . This induction of neuronal toler ance to ischemia is similar to that reported previously using sublethal ischemia as the preconditioning stimulus (Kitagawa et a!., 1991; Kirino et a!., 1991; Glazier et a!., 1994) . Cortical spreading depression is characterized by transient perturbations of electrical activity, ion homeo stasis, and metabolite levels that resemble the initial stages of ischemia (Hansen and Zeuthen, 1981; Lauritzen Levels of the 72-kDa heat-shock protein (hsp72) mRNA were not significantly increased by CSD, except for a small elevation (20%) at 2 hours recovery. Levels of the 73-kDa heat-shock cognate (hsc73) mRNA were slightly, but significantly, in creased at 2 and 24 hours of recovery. Finally, levels of mRNA for protease nexin-l and glutamine synthetase were not signifi cantly altered by CSD at any time studied. The current results support the hypothesis that neuronal tolerance to ischemia after et aI., 1990). Thus, the mechanisms by which CSD and sublethal ischemia induce neuronal tolerance may share common features. However, little is known about the molecular alterations that mediate the induction of neu ronal tolerance after CSD or ischemia.
Previous studies have demonstrated that CSD induces rapid expression of immediate-early genes (lEG) such as c-fos (Herrera and Robertson, 1990; Herdegen et a!., 1993) . Many lEG encode transcription factors and, thus, may mediate expression of neuroprotective target genes. In situ hybridization studies have indicated that CSD also causes a rapid elevation of brain-derived neurotrophic factor (BDNF) mRNA (Kokaia et a!., 1993) . Brain derived neurotrophic factor has been reported to protect neurons both in vitro and in vivo (Ghosh et a!., 1994; Beck et a!., 1994) . Further, BDNF is induced by a variety of cerebral insults and may function to limit the extent of brain damage (Lindvall et a!., 1994) . Thus, BDNF is a prime candidate for mediating the induction of neuronal tolerance to ischemia after CSD. Accordingly, the first objective of the present study was to quantify the time course of expression of c-fos and BDNF mRNA after CSD using Northern blot analysis.
Cortical spreading depression has also been shown to induce delayed expression of glial fibrillary acid protein mRNA LEVELS MODULATED BY SPREADING DEPRESSION 1309 (GFAP), a marker of reactive astrocytes (Kraig et a!., 1991) . Reactive astrocytes may function to protect neu rons from ischemia by releasing trophic factors or by scavenging glutamate. Protease nexin-l is a serine pro tease inhibitor that was originally identified as a neuro trophic factor derived from glia (Monard et aI., 1973) . Increased expression of nexin-l has been demonstrated in GFAP-positive astrocytes after ischemia (Hoffmann et aI., 1992) . Moreover, nexin-l has been reported to pro tect neurons against glucose deprivation (Smith Swintosky et a!., 1995) . However, the effect of CSD on nexin-l expression has not been previously examined. Thus, a second objective of the present study was to determine whether CSD alters the level of nexin-l mRNA. In addition, the effects of CSD on mRNA levels of tissue plasminogen activator (tPA), one of the serine proteases inhibited by nexin-l, were also measured. Neu ronal depolarization has been reported to increase the expression and secretion of tPA (Qian et aI., 1993; Gual andris et aI., 1996) . Furthermore, tPA has been impli cated as a pathogenic factor in excitotoxic neuronal in jury (Tsirka et aI., 1995) . Thus, alterations in the expres sion of nexin-l and tP A after CSD may modulate the vulnerability of cortical neurons to ischemia.
Astrocytes also play an important role in scavenging and metabolizing glutamate. Glutamine synthetase is the rate-limiting enzyme in the metabolism of glutamate and is localized primarily in astrocytes (Martinez-Hernandez et aI., 1977) . Facilitation of glutamate metabolism would be expected to protect neurons from ischemia by dimin ishing their exposure to glutamate. Glutamine synthetase activity and immunoreactivity were reported to increase rapidly after cerebral ischemia (Petito et aI., 1992) . How ever, the influence of CSD on expression of glutamine synthetase has not been previously examined. Thus, an additional objective of the present study was to deter mine whether CSD alters the level of glutamine synthe tase mRNA.
Finally, expression of the 72-kDa heat-shock protein (hsp72) has been associated with induction of neuronal tolerance in several experimental models of ischemic preconditioning (Kirino et aI., 1991; Glazier et aI., 1994) . However, in situ hybridization studies have failed to de tect increases in hsp72 mRNA after CSD (Nowak et aI., 1991; Kobayashi et aI., 1995) . Thus, hsp72 is not likely to have an important role in the induction of neuronal tolerance after CSD. Recently, the 27-kDa heat-shock protein was reported to be strongly induced after CSD, suggesting that other stress proteins may contribute to neuronal tolerance after CSD (Plumier et aI., 1997) . The effect of CSD on expression of the 73-kDa heat-shock cognate (hsc73), a close relative of hsp72, has not been previously examined. Thus, the final objective of the present study was to determine whether CSD alters the level of hsc73 mRNA.
Preliminary results of this work have been reported previously (Karik6 et aI., 1997) .
MATERIALS AND METHODS

Induction of cortical spreading depression
All procedures were performed in strict accordance with the NIH Guide for Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee.
Cortical spreading depression was produced in 15 male Wi star rats using methods described previously (Kobayashi et aI., 1995) . In brief, anesthesia was induced with halothane, and the animals were intubated and ventilated mechanically with a mixture of I % halothane, 25% 020 balance N20. A cannula was placed in the tail artery for blood sampling, and core tempera ture was maintained at 37.5°C using a rectal probe connected to a heating lamp. The head of the animal was placed in a stereo taxic frame, and small burr holes (diameter, 2 mm) were made bilaterally over the frontal cortex, leaving the dura intact. Cor tical spreading depression was induced by placing filter paper soaked with 2 mollL KCl into one of the burr holes, chosen randomly in each animal. In the contralateral hemisphere, filter paper soaked with physiologic saline served as a control. The filter papers were replaced every 20 minutes for a period of 2 hours. In 5 animals, the blood flow response to CSD was mea sured using laser-Doppler flowmetry. In these animals, burr holes (diameter, 2 mm) were made bilaterally over the parietal After application of KCl for 2 hours, the animals were di vided among three groups. In the first group (n = 5), the animals were killed immediately using an overdose of halo thane. The remaining animals were permitted to recover for 2 hours (n = 5) or 24 hours (n = 5) before killing. Two animals served as unoperated on controls. One additional animal was used as a positive control for hsp72 mRNA. In this animal, forebrain ischemia was produced for 20 minutes, followed by reperfusion for 2 hours, using previously described methods (Kobayashi et aI., 1995) . 
Northern blot analysis
eDNA probes
Probes for c-fos, BDNF, nexin-I, and glutamine synthetase were rat-specific purified cDNA inserts generated by reverse transcription-polymerase chain reaction cloning using plasmid pCR II (Invitrogen, San Diego, CA, U.S.A.). Primers were designed using sequence information obtained from the Gen Bank (R90.0), and the specificity of the probes was confirmed by sequencing (DNA Sequencing Facility, University of Penn sylvania).
c-fos. A 706-bp cDNA was generated from template RNA of rat cerebral cortex subjected to CSD. The specific 5' primer (5'-CGCAGAGCATCGGCAGAA-3') and 3' primer (5'
GCGCAGCTAGGGAAGGAGTCA-3') corresponding to nucleotides (nt) 493 through 510 and nt 1, 198 through 1, 178 of the coding sequence of rat c-fos cDNA were used (Accession: X06769). This probe detected a single 2.l-kb transcript in RNA samples from rat brain.
BDNF.
A 777-bp cDNA was generated from template RNA of rat cerebral cortex subjected to CSD. The specific 5' primer (5' -CTGCCTTGATGTTT ACTT -3') and 3' primer (5'
CAGGAAGTGTCTATCCTTAT-3') corresponding to nt 936 to 953 and nt 2,839 to 2,820 of the exons of rat gene for BDNF were used (Accession: X67 107 and D10938, respectively).
This probe detected transcripts in two major bands (1.6 to 1.8 kb and 4.2 to 4.4 kb), both of which were used for quantitation of BDNF mRNA.
Nexin-l. A 10 17-bp cDNA was generated from template RNA of normal rat brain using 5' primer (5'
CCAGGTTTTCAATCAGAT-3') and 3' primer (5' GGCCTGTCTACTATAAAC-3') corresponding to nt 108 to 125 and nt 1, 124 to 1, 107 of the coding sequence of rat nexin-l cDNA (Accession: M 17784). This probe detected a single tran script of approximately 2.0 kb.
Glutamine synthetase. A 717-bp cDNA was generated from template RNA of rat cerebral cortex subjected to CSD. The specific 5' primer (5'-CCCCTGGTTTGGAATGGA-3') and 3'-primer (5'-TCGTCGCCAGTTTCGTTG-3') corresponding to nt 515 to 532 and nt 1,23 1 to 1,2 14 of rat glutamine syn thetase cDNA were used (Accession: M29579). This probe detected a single 2.8-kb transcript. Both of the inducible transcripts were used to quantitate hsp72 mRNA and the constitutive transcript was used to quantitate hsc73 mRNA. 
Statistical analysis
Differences in mean values of arterial variables between groups were tested for statistical significance using one-way analysis of variance. Differences in mean values of mRNA levels between hemispheres were tested for statistical signifi cance using a paired t test.
RESULTS
Physiologic variables
There were no significant differences in arterial vari ables between recovery groups ( Table 1) . One of the 24-hour recovery animals exhibited arterial acidosis and hypotension; thus, the results from this animal were ex cluded from the statistical analysis. In animals monitored for cortical blood flow, CSD appeared as an abrupt in crease in flow, rising to a peak several times higher than baseline and returning to control levels within 1 to 2 minutes (Fig. 1) . Application of KCI for 2 hours trig gered 11 ± 6 episodes of CSD (mean ± SD, n = 5) in the ipsilateral cortex. Episodes of CSD were not detected in the contralateral cortex.
Levels of mRNA
Application of KCI markedly altered mRNA levels in several regions of the ipsilateral cortex (Fig. 2) . In the frontal cortex, which includes the site of KCI application, ipsilateral levels of c-fos, BDNF, tPA, and hsp72 mRNA were higher than those in the contralateral cortex and those in the cortex of control animals (Fig. 2, region F) . In the parietal cortex, ipsilateral levels of c-fos, BDNF, and tP A mRNA were also increased, whereas hsp72 mRNA was near the level of detection (Fig. 2, region P) . In the occipital cortex, ipsilateral levels of c-fos, BDNF, and tPA mRNA remained higher than those in the con tralateral cortex, but were lower than those in the frontal and parietal regions (Fig. 2, region 0) .
The timecourse of changes in mRNA levels after CSD was determined in parietal cortex to avoid the local ef fects of KCI in frontal cortex (Fig. 3) . At the end of the period of KCI application (0 hours of recovery), ipsilat eral levels of c-fos mRNA were markedly increased in all animals (Figs. 3 and 4) . At 2 hours of recovery, c-fos mRNA in the ipsilateral cortex remained elevated, but Changes in cortical blood flow during recurrent cortical spreading depression (CSD). KCI (2 moUl) was applied to the intact dura over the frontal cortex of one hemisphere, and blood flow was monitored over the parietal cortex of the ipsilateral and contralateral hemispheres using laser-Doppler flowmetry. In the ipsilateral cortex, CSD appeared as a sharp increase in cortical blood flow. Episodes of CSD were not detected in the contralat eral cortex.
the levels were lower than those at 0 hours of recovery. At 24 hours of recovery, c-fos mRNA in the ipsilateral cortex was below the level of detection in 3 of 5 animals, but was expressed at high levels in the remaining 2 ani mals. One of the latter animals was excluded from the study owing to arterial abnormalities (see above). This animal also exhibited bilateral elevation of c-fos and hsp72 mRNA. In the remaining 14 animals, mRNA lev els in the contralateral cortex were similar to those in unoperated on controls (Fig. 3, controls) . Cortical spreading depression also caused a robust in crease in ipsilateral levels of BDNF mRNA at 0 and 2 hours of recovery (Figs. 3 and 5) . However, by 24 hours of recovery, BDNF mRNA was near the level of detec tion in both hemispheres, with the exception of the ex cluded animal. Levels of hsp72 mRNA were barely de tectable in the ipsilateral cortex in most of the animals at o and 2 hours of recovery (Fig. 3) . However, in one of the animals at 0 hours of recovery, there was moderate induction of hsp72 mRNA in the ipsilateral cortex. In terestingly, in this animal, a total of 21 episodes of CSD were recorded during the 2-hour KCI application period. As noted above, robust expression of hsp72 mRNA oc curred bilaterally in the excluded animal (24 hours of recovery). Quantitation of hsp72 mRNA levels indicated a statistically significant small (20%) increase at 2 hours of recovery, but not at 0 or 24 hours of recovery (Fig. 6) . Similarly, levels of hsc73 mRNA were significantly higher (10% to 20%) in the ipsilateral cortex than in the contralateral cortex at 2 and 24 hours of recovery, but not at 0 hours of recovery (Fig. 7) . Cortical spreading de pression also caused a significant elevation of tP A mRNA in the ipsilateral cortex at 0 and 2, but not 24 hours of recovery (Figs. 3 and 7) . Finally, there were no significant differences between hemispheres in the levels of nexin-1 and glutamine synthetase mRNA at any time studied (Figs. 3 and 7) .
DISCUSSION
Preconditioning the brain with CSD induces a lasting tolerance of neurons to a subsequent episode of ischemia (Kawahara et ai., 1995; Kobayashi et aI., 1995; Mat sushima et ai., 1996) . However, the long-term molecular alterations after CSD that contribute to the acquisition of neuronal tolerance remain poorly defined. The present results confirm and extend previous findings that CSD triggers transient induction of c-fos and BDNF mRNA (Kokaia et ai., 1993; Kobayashi et aI., 1995) . In addition, the results demonstrate that CSD causes rapid elevation of tP A mRNA, but does not cause substantial changes in
Regional changes in mRNA levels after CSD. Autoradio graphic images of Northern blots are shown for c-fos, brain derived neurotrophic factor (BDNF), 72-kDa heat-shock protein (hsp72), 73-kDa heat-shock cognate (hsc73), tissue plasmino gen activator (tPA), and glyceraldehyde-3-phosphate dehydroge nase (GAPDH) mRNA. RNA samples were prepared from the cerebral cortex of an unoperated on animal (Control), from the frontal cortex (KCI site) of a CSD animal (CSD), and from the frontal (F), parietal (P), and occipital (0) cortex of both hemi spheres in an animal at 0 hours of recovery after 2 hours of application of 2 mol/l KCI to the intact dura over the right frontal cortex. lanes with samples ipsilateral to the KCI application are marked with the target symbol. See Fig. 1 hsp72, hsc73, nexin-l, or glutamine synthetase mRNA at the times studied. Thus, the induction of neuronal toler ance after CSD may be mediated by changes in expres sion of FOS, BDNF, and tPA, but is not likely to involve altered expression of hsp72, hsc73, nexin-l, or glutamine synthetase. Previous investigations have demonstrated that KCI induced CSD triggers rapid expression of FOS-like im munoreactivity in the ipsilateral cerebral cortex (Herrera and Robertson, 1990; Herdegen et aI., 1993) . FOS-like immunoreactivity was detected as early as I hour after application of KCI, with maximal expression occurring at 3 hours. In our own prior work, in situ hybridization indicated that c-fos mRNA increased by the end of the KCI application period and at 2 hours of recovery, but returned to control by 24 hours (Kobayashi et aI., 1995) . To our knowledge, the present results are the first quan titative description of the timecourse of steady-state lev els of c-fos mRNA after CSD. Consistent with the pre vious results, the present study clearly demonstrates that CSD triggers a robust elevation of c-fos mRNA by the end of the 2-hour KCl application and that levels of c-fos mRNA decline rapidly thereafter. Presumably, elevation of c-fos mRNA is mediated by alterations in intracellular Ca 2+ and cyclic adenosine monophosphate (cAMP), al terations that are known to occur during CSD (Krivanek, Effect of CSD on c-fos mRNA levels. Densitometric analyses were performed on the corresponding autoradiographic images in Fig. 3 . For each sample lane, the optical density of the c-fos mRNA band was normalized with that of GAPDH mRNA. Bars represent mean values of 5 animals (4 animals at 24 hours), and brackets represent standard deviations. Asterisks denote significant differences from the value in the corresponding con tralateral cortex, 1977; Hansen and Zeuthen, 1981) . Because FOS func tions as part of a transcriptional activating system, its induction after CSD could potentiaJly alter the expres sion of neuroprotective proteins. However, direct evi dence linking FOS to expression of neuroprotective pro teins after CSD is currently lacking.
The present results extend previous in situ hybridiza tion studies demonstrating that BDNF mRNA is also elevated by CSD (Kokaia et aI., 1993) . The rapid eleva tion of BDNF mRNA after CSD is similar to that re ported in rat hippocampus after focal trauma or electrical stimulation, occurring in both cases in the presence of inhibitors of protein synthesis (Hughes et aI., 1993; Lau terborn et aI., 1996) . Thus, similar to c-fos mRNA, BDNF mRNA may be induced immediately by CSD without the need for synthesis of protein transcription factors. Indeed, examination of the promoter sequence of exon III reveals the presence of a cAMP-response ele ment, which may account for the rapid increase in BDNF mRNA after CSD. However, BDNF mRNA levels did not decline in paraJlel with c-fos mRNA between 0 and 2 hours of recovery. The timecourse differences between BDNF and c-fos mRNA levels after CSD may be caused by differences in (1) the duration of active transcription or (2) the half-life of the two transcripts. However, the present observations cannot distinguish between these possible explanations.
More importantly, the influence of BDNF expression after CSD on the tolerance of neurons to ischemia is likely to be beneficial. Brain-derived neurotrophic factor has been shown to be neuroprotective in vitro (Ghosh et aI., 1994) . Brain-derived neurotrophic factor has also been reported to protect neurons in rodent models of cerebral ischemia (Beck et aI., 1994 mRNA after CSD is brief, relative to the timecourse of induction of neuronal tolerance to ischemia (Kobayashi et aI., 1995; Matsushima et aI., 1996) . Thus, neuronal tolerance has been demonstrated as early as 24 hours after CSD, a time at which levels of BDNF mRNA have returned to normal. Because the timecourse of induction of BDNF protein after CSD is not known, further work is needed to determine the role of BDNF in CSD-induced neuronal tolerance to ischemia. Increased levels of tP A mRNA have been demon strated previously after convulsive seizures, kindling, long-term potentiation, and motor learning in the rat (Qian et aI., 1993; Seeds et aI., 1995) . Subsequent work has indicated that KCI-induced neuronal depolarization causes rapid secretion of tP A from PC 12 cells and el evation of tP A activity in mouse hippocampus (Gualan dris et aI., 1996) . These results suggest that depolariza tion of neurons by physiologic or pathologic stimuli in creases the expression of tP A. The present findings showing increased levels of tPA mRNA after CSD are consistent with this suggestion. The rapid elevation of tPA mRNA after CSD is also consistent with the pres ence of a consensus cAMP-responsive element in the promoter of the rat tP A gene (Holmberg et aI., 1995) .
However, the consequences of tP A expression with respect to neuronal tolerance are controversial. Increased activity of tPA has been associated with neurite out growth, migration, and regeneration (Krystosek and Seeds, 1981) . Thus, expression of tP A after CSD might facilitate synaptic remodeling, thereby promoting neuro nal recovery after an episode of ischemia. However, re cent evidence suggests that tPA activity may adversely affect neuronal injury after excitotoxic and ischemic in sults (Tsirka et aI., 1995) . Mice lacking the tPA gene exhibited increased tolerance of hippocampal neurons to kainic acid, suggesting that tP A may be an important mediator of excitotoxic neuronal death. This apparent discrepancy may be explained, in part, by two significant differences in tP A expression between mouse brain and rat brain. First, the mouse tP A gene lacks a cAMP response element and, thus, is not an IEG in the mouse (Holmberg et aI., 1995) . Second, in mouse brain, at least in hippocampus, tP A was found to be expressed primar ily in microglia (Tsirka et aI., 1995) . In rat brain, tP A mRNA has been localized to ventricular ependyma, me ninges, blood vessels, Purkinje cell layer of the cerebel lum, scattered small cells throughout the brain, and a subpopulation of large cells (presumed neurons) in brain stem and cerebral cortex (Ware et aI., 1995) . Thus, the role of tP A in neuronal injury in rat brain may differ from that in mouse brain.
The present results indicate that CSD caused signifi cant increases in the levels of hsp72 and hsc73 mRNA at 2 hours of recovery and of hsc73 nRNA at 24 hours of recovery. However, the biologic significance of the small increases (10% to 20%) is questionable. Nevertheless, overexpression of hsp70 by only 10% to 12% in Dro sophila melanogaster during a heat stress was sufficient to improve subsequent survival at normal temperatures (Tatar et aI., 1997) . Thus, it is difficult to exclude the possibility of a contribution of hsp72 or hsc73 to the induction of neuronal tolerance after CSD. At present, however, there is no published evidence that CSD in creases expression of hsp72 protein after CSD. In our own studies, hsp72 immunoreactivity has not been de tected in cortical regions apart from the site of KCl ap plication (unpublished observations). Thus, in our opin ion, it is unlikely that CSD induces biologically signifi cant amounts of hsp72 or hsc73 proteins.
Finally, the present results indicate that CSD failed to cause significant alterations in mRNA levels for two other putative neuroprotective proteins, nexin-l and glu tamine synthetase. Thus, these proteins are unlikely to have a role in the neuronal tolerance induced by CSD. It should be cautioned, however, that whereas expression of many proteins is regulated at the level of transcription, expression of other proteins is regulated at the level of translation. Because the present study examined levels of mRNA only, the possibility that CSD alters protein lev els or enzymatic activity without changing mRNA levels cannot be excluded.
